Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy.

@article{Andrzejewski2015FeasibilityOD,
  title={Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy.},
  author={Piotr Andrzejewski and Peter Kuess and Barbara Kn{\"a}usl and Katja Pinker and Petra Georg and Johannes Knoth and Daniel Berger and Christian Kirisits and Gregor Goldner and Thomas H Helbich and Richard Poetter and Dietmar Georg},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2015},
  volume={117 3},
  pages={509-14}
}
BACKGROUND AND PURPOSE Advancements in imaging and dose delivery enable boosting of the dominant intraprostatic lesions (DIL), while maintaining organs-at-risk (OAR) tolerances. This study aimed to assess the feasibility of DIL boosting for volumetric modulated arc therapy (VMAT), intensity modulated proton therapy (IMPT) and high dose rate brachytherapy (HDR-BT). MATERIAL AND METHODS DILs were defined on multiparametric magnetic resonance imaging and fused with planning CT for twelve… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
3 Extracted Citations
44 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 44 references

Meta analysis of alpha/beta ratio for prostate cancer in the presence of an overall time factor. Bad news, good news or no news

  • IR Vogelius, SM Bentsen
  • Int J Radiat Oncol Biol Phys 2013;85:89–94
  • 2013

Similar Papers

Loading similar papers…